erebral vasospasm is an important cause of mor- tality and morbidity in patients with aneurysmal subarachnoid hemorrhage (SAH), but its pathogenesis has not yet been fully clarified.' Some reports suggest a possible role of the platelet system in this pathogenesis. Time-sequential changes of platelet functions were examined with affirmative results in patients with symptomatic cerebral vasospasm,23 and multiple cerebral microthrombi were observed in patients who died of fetal cerebral vasospasm.45 Thromboxane A2, which is synthesized mainly in circulating platelets and released from aggregating platelets, has been suggested to play some role in this pathological condition.6 However, the factors that induce platelet adhesion and aggregation during cerebral vasospasm have not been explained. Some current investigations indicate the possible role of endothelial damage in cerebral vasospasm. Ultrastructural observation revealed various morphological changes of endothelial cells after SAH.7,8Disruption of the blood-arterial wall barrier after SAH has also been suggested to be involved in the pathogenesis of cerebral vasospasm. 9 arterial blood (3 mL) obtained from the femoral artery was slowly injected over 1 minute, and the cats were kept in the head-down position for 30 minutes to facilitate the blood accumulation in the basal cisterns. Then the cats were permitted to awaken and were returned to the kennel. Forty-eight hours after the first cisternal injection, the second injection was carried out in the same manner.
One hour or 2, 4, 7, or 14 days after the first cisternal blood injection, the cats were similarly anesthetized and were intubated endotracheally to control their respiration with an animal respirator (model R-60, Aika Inc, Tokyo, Japan). The subjects were divided into two groups: the ADP-infused group and the ADP-uninfused group (Table) . In the ADP-infused group, a polyethylene catheter was inserted via the right axillar artery, and its tip was advanced to the right subclavian artery at the origin of the right vertebral artery. The right costocervical trunk and the right internal thoracic artery were ligated at their origin, and the subclavian artery was ligated together with the catheter tip so that the catheter became wedge-shaped (Fig 1) . Through the catheter, 40 mg/kg of ADP (Sigma Chemical Co, St Louis, Mo) dissolved in 3 mL saline solution was infused into the right vertebral artery over 3 minutes with an auto- matic injector (model STC-521, Terumo Inc, Tokyo, Japan) to activate circulating platelets. Immediately after the end of ADP infusion, the cats were killed by perfusion-fixation, and their brains were taken out. In the other three cats without cisternal blood injection, ADP was infused in the same manner after the basilar artery was exposed transclivally, and, using a surgical microscope, dynamic changes were observed in the caliber of the artery during ADP infusion. Immediately after the completion of ADP infusion, those cats were also killed by perfusion-fixation.
For evaluation of serial morphological changes on the luminal surface of the basilar artery after SAH per se, in the ADP-uninfused group 12 cats were killed by perfusion-fixation without ADP infusion at the same intervals after the first cisternal blood injection.
Scanning electron microscopic observation was conducted as follows. A brief perfusion with saline solution folds, but no platelet adhesion is seen (C). Bar, 10 gim.
was started through a catheter placed in the ascending aorta, followed by perfusion with 1.5% glutaraldehyde in 0.1 mol/L phosphate buffer (pH 7.4) under a pressure of 130 mm Hg. Immediately after the perfusion-fixation, the brain was taken out, and the basilar artery was dissected. The artery was immersed in 2.5% glutaraldehyde in 0.1 mol/L phosphate buffer (pH 7.4) for 24 hours at 4°C and incised longitudinally under a surgical microscope. The specimens were postfixed with 1% osmium tetroxide in 0.1 mol/L phosphate buffer (pH 7.4) for 90 minutes at 4°C, dehydrated in a graded ethanol series, dried at the critical point, and sputtercoated with gold (Eiko Engineering Co, Tokyo, Japan). The luminal surface was observed with an SEM (Hitachi S-405, Hitachi, Tokyo, Japan). In the ADP-uninfused group, the serial changes of the intima after SAH, such as intercellular gap, ballooning, and crater, were examined, counting these findings within a 35 x42 -gm2 field at a magnification of x2000 in 10 nonoverlapping areas in each specimen. In the ADP-infused group, the degree of platelet adhesion and aggregation on the luminal surface was mainly examined, counting the adhering platelets within a 35x42-gm2 field at a magnification of x2000 in 10 nonoverlapping areas in each specimen. Results In normal controls, the luminal surface of the basilar artery was smooth and flat with regularly arranged endothelial cells with obvious nuclear protrusions, and cellular borders were well defined with marginal folds (Fig 2) .
In cats without ADP infusion, 1 hour after SAH, longitudinal folds appeared on the luminal surface, but cell margins were still distinct (Fig 3A) . Two days after SAH, endothelial cells protruded with indistinct cell margins, and intercellular gaps began to appear. Four days after SAH, intercellular gaps became more marked (Fig 3B) , and cellular balloonings and crater formations began to be observed (Fig 3C) . These changes persisted until 7 days after SAH. Fourteen days after SAH, such findings were minimal with vestigial longitudinal folds, and cellular marginal folds reappeared clearly (Fig 3D) .
In the surgical microscopic observation of the transclivally exposed basilar artery in cats without SAH, intra-arterial ADP infusion produced immediate constrictions of the basilar artery and the right vertebral artery where ADP was perfused (Fig 4A and 4B) . The luminal surface of the constricted basilar artery showed longitudinal folds under an SEM, which might be a result of this vasoconstriction. However, neither platelet adhesion nor aggregation could be noted (Fig 4C) .
When the intra-arterial ADP infusion was conducted on cats with mimic SAH, no platelet adhesion on the luminal surface was observed 1 hour after the first cisternal blood injection. Two days after SAH, however, a few platelets could be observed adhering to the luminal surface (Fig SA) . When ADP was infused 4 days after SAH, a large number of platelets and a few erythrocytes adhered all over the intima (Fig SB and  5C ), and these findings persisted until 7 days after SAH. Fourteen days after SAH, adhesion or aggregation of blood cells became minimal. Time-sequential changes of platelet adhesion or aggregation were well expressed quantitatively (Table) .
Discussion
In the present study, an intra-arterial ADP infusion method for activating circulating platelets was introduced to evaluate the serial changes of anti-plateletaggregating activity in endothelial cells in vivo after experimental SAH, and the degree of platelet adhesion and aggregation on the arterial luminal surface was evaluated with an SEM. The ADP infusion into cerebral vessels has formerly been used in studies for transient ischemic attacks or vascular changes induced by platelet aggregation.20,21 Fujimoto et a'21 studied the vascular changes of the middle cerebral artery by injecting ADP into the carotid artery in rabbits and reported that no vascular injury was recognizable immediately after the ADP injection but at 60 minutes endothelial degeneration with platelet adhesion was seen, and that such changes were not seen when blood in the cerebral circulation was replaced by physiological saline before the ADP injection. Therefore, the possibility of endothelial cell injury by activated platelets or by ADP per se can be excluded by evaluating the vessel wall immediately after ADP infusion.
In the ADP-uninfused group, platelets adhered neither to endothelial cells nor to intercellular gaps after SAH. Therefore, in our experimental SAH model, the intercellular gaps are not suggested to involve exposed basal lamina.
In cats without mimic SAH, constriction of the basilar artery was observed during ADP infusion, and its luminal surface showed longitudinal folds. This vasoconstriction may be caused by mediators released from activated platelets such as thromboxane A2, serotonin, and PGF2a or by ADP direct effect. But no platelet adhesion on the luminal surface could be seen. In the ADP-infused group, platelet adhesion on the luminal surface was scarcely observable until 2 days after SAH, while marked platelet adhesions or aggregations were seen 4 to 7 days after SAH. These findings suggest that the anti-platelet-aggregating activity of endothelial cells was impaired 4 to 7 days after SAH. In the ADP-uninfused group, on the other hand, cellular balloonings, crater formations, and intercellular gaps were notable 4 to 7 days after SAH. Such morphological changes are considered to be associated with the functional impairments of endothelial cells and to represent their regressive degeneration. However, this functional impairment may not be irreversible, because platelet adhesion on the luminal surface was reduced 14 days after SAH. Sasaki et al '6 reported that the synthetic activity of PGI2 in the canine basilar artery exposed to subarachnoid blood injection had diminished remarkably on days 3 and 8. Nakamura et al14 indicated that the 6-keto-PGFl, levels in the feline basilar and pial arteries had decreased after the production of SAH. Nakagomi et al'3 reported that the vasodilatory response to ATP of the basilar artery was suppressed in the rabbits killed 2 days after SAH and suggested that the production of EDRF by endothelial cells was inhibited after SAH. Results of our study correlated well with those in vitro studies.
We reported that the patients with delayed ischemic symptoms due to cerebral vasospasm after aneurysmal SAH showed platelet hyperactivity.3 In addition, multiple cerebral microthrombi were observed in patients who died of fetal cerebral vasospasm.45 Furthermore, some degree of efficacy of antiplatelet drugs in the prevention of symptomatic cerebral vasospasm was reported.6'22 Therefore, the platelet system may play an important role in cerebral ischemia during cerebral vasospasm. However, the factor that induces platelet adhesion and aggregation during cerebral vasospasm has not been explained. Our results suggest that the impairment of anti-platelet-aggregating activity of endothelial cells can be a factor causing platelet adhesion and aggregation during cerebral vasospasm.
